Literature DB >> 21509678

History of multiple myeloma.

Robert A Kyle1, David P Steensma.   

Abstract

Multiple Myeloma has been recognized since Ancient Times. The first well-documented case was reported in 1844 by Samuel Solly. The most commonly recognized case is that of Thomas Alexander McBean, a highly respectable tradesman from London in 1850. Mr. McBean excreted a large amount of protein that was described by Henry Bence Jones in the middle of the 19th century. Jones was a well-known physician and made many contributions to medicine. One of the best known cases of multiple myeloma was that of Dr. Loos that was reported by Otto Kahler. The recognition of plasma cells and subsequently their product, a monoclonal protein has been described in detail. The authors have reviewed the treatment of multiple myeloma including the novel agents, thalidomide, bortezomib and lenalidomide.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21509678     DOI: 10.1007/978-3-540-85772-3_1

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  4 in total

1.  Real-world utilisation of ASCT in multiple myeloma (MM): a report from the Australian and New Zealand myeloma and related diseases registry (MRDR).

Authors:  Krystal Bergin; Cameron Wellard; Bradley Augustson; Rachel Cooke; Hilary Blacklock; Simon J Harrison; Joy Ho; Tracy King; Hang Quach; Peter Mollee; Patricia Walker; Elizabeth Moore; Zoe McQuilten; Erica Wood; Andrew Spencer
Journal:  Bone Marrow Transplant       Date:  2021-05-19       Impact factor: 5.483

Review 2.  Multiple Myeloma: Challenges Encountered and Future Options for Better Treatment.

Authors:  Srijit Das; Norsham Juliana; Noor Anisah Abu Yazit; Sahar Azmani; Izuddin Fahmy Abu
Journal:  Int J Mol Sci       Date:  2022-01-31       Impact factor: 5.923

3.  Immunoglobulin A Lambda Multiple Myeloma in a Patient with HIV: An Unusual Cause of Massive Ascites.

Authors:  Molham Abdulsamad; Naeem Abbas; Harish Patel; Bhavna Balar; Misbahuddin Khaja
Journal:  Case Rep Gastroenterol       Date:  2017-04-10

4.  Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activation.

Authors:  Morten Nørgaard Andersen; Maja Ludvigsen; Niels Abildgaard; Irma Petruskevicius; Rikke Hjortebjerg; Mette Bjerre; Bent Honoré; Holger J Møller; Niels F Andersen
Journal:  Onco Targets Ther       Date:  2017-04-04       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.